Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].
Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Chabbert-Buffet N, Daraï E, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, de la Motte Rouge T, Ferron G, Devouassoux-Shisheboran M, Kurtz JE, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I. Rousset-Jablonski C, et al. Among authors: gompel a. Bull Cancer. 2018 Mar;105(3):299-314. doi: 10.1016/j.bulcan.2017.10.032. Bull Cancer. 2018. PMID: 29397916 French.
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers.
Rousset-Jablonski C, Selle F, Adda-Herzog E, Planchamp F, Selleret L, Pomel C, Daraï E, Chabbert-Buffet N, Pautier P, Trémollières F, Guyon F, Rouzier R, Laurence V, Chopin N, Faure-Conter C, Bentivegna E, Vacher-Lavenu MC, Lhomme C, Floquet A, Treilleux I, Lecuru F, Gouy S, Kalbacher E, Genestie C, Thibault MR, Ferron G, Devouassoux M, Kurtz JE, Provansal M, Namer M, Joly F, Pujade-Lauraine E, Grynberg M, Querleu D, Morice P, Gompel A, Ray-Coquard I. Rousset-Jablonski C, et al. Among authors: gompel a. Eur J Cancer. 2019 Jul;116:35-44. doi: 10.1016/j.ejca.2019.04.018. Epub 2019 Jun 3. Eur J Cancer. 2019. PMID: 31170563
Hormone therapy and ovarian cancer.
Trémollieres F, Lopès P, Gompel A; Groupe d'Etude sur la Ménopause et le Vieillissement hormonal. Trémollieres F, et al. Among authors: gompel a. Lancet. 2015 Sep 12;386(9998):1038. doi: 10.1016/S0140-6736(15)00139-7. Lancet. 2015. PMID: 26382992 No abstract available.
[HRT and ovarian cancer risk].
Lopes P, Trémollières F, Gompel A. Lopes P, et al. Among authors: gompel a. Gynecol Obstet Fertil. 2015 Apr;43(4):324-5. doi: 10.1016/j.gyobfe.2015.02.015. Epub 2015 Mar 26. Gynecol Obstet Fertil. 2015. PMID: 25819391 French. No abstract available.
Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study.
Gernier F, Gompel A, Rousset-Jablonski C, Kalbacher E, Floquet A, Berton-Rigaud D, Tredan O, Alexandre J, Follana P, Zannetti A, Dohollou N, Grellard JM, Clarisse B, Licaj I, Ahmed-Lecheheb D, Fauvet R, Pautier P, Joly F. Gernier F, et al. Among authors: gompel a. Gynecol Oncol. 2021 Dec;163(3):598-604. doi: 10.1016/j.ygyno.2021.10.001. Epub 2021 Oct 11. Gynecol Oncol. 2021. PMID: 34649724 Free article.
Screening for familial cancer risk: Focus on breast cancer.
Rousset-Jablonski C, Gompel A. Rousset-Jablonski C, et al. Among authors: gompel a. Maturitas. 2017 Nov;105:69-77. doi: 10.1016/j.maturitas.2017.08.004. Epub 2017 Aug 7. Maturitas. 2017. PMID: 28818315 Review.
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.
Joly F, Ahmed-Lecheheb D, Kalbacher E, Heutte N, Clarisse B, Grellard JM, Gernier F, Berton-Rigaud D, Tredan O, Fabbro M, Savoye AM, Kurtz JE, Alexandre J, Follana P, Delecroix V, Dohollou N, Roemer-Becuwe C, De Rauglaudre G, Lortholary A, Prulhiere K, Lesoin A, Zannetti A, N'Guyen S, Trager-Maury S, Chauvenet L, Abadie Lacourtoisie S, Gompel A, Lhommé C, Floquet A, Pautier P. Joly F, et al. Among authors: gompel a. Ann Oncol. 2019 May 1;30(5):845-852. doi: 10.1093/annonc/mdz074. Ann Oncol. 2019. PMID: 30851097 Free article.
[Hormone replacement therapy after endometrial or ovarian cancer].
Daraï E, Gompel A, Deval B, Laplace C, Lemoine A, Labeyrie E, Neu AM, Poitout P. Daraï E, et al. Among authors: gompel a. Gynecol Obstet Fertil. 2000 Mar;28(3):198-204. Gynecol Obstet Fertil. 2000. PMID: 10786400 Review. French.
Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology.
Gourdy P, Bachelot A, Catteau-Jonard S, Chabbert-Buffet N, Christin-Maître S, Conard J, Fredenrich A, Gompel A, Lamiche-Lorenzini F, Moreau C, Plu-Bureau G, Vambergue A, Vergès B, Kerlan V. Gourdy P, et al. Among authors: gompel a. Ann Endocrinol (Paris). 2012 Nov;73(5):469-87. doi: 10.1016/j.ando.2012.09.001. Epub 2012 Oct 15. Ann Endocrinol (Paris). 2012. PMID: 23078975
346 results